#152160

Anti-Cytochrome P450 2E1 [M12P4H2]

Cat. #152160

Anti-Cytochrome P450 2E1 [M12P4H2]

Cat. #: 152160

Sub-type: Primary antibody

Unit size: 100 ug

Availability: 1-2 weeks

Target: Cytochrome P450, family 2, subfamily E, polypeptide 1 (CYP2E1)

Class: Monoclonal

Application: IHC ; WB

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Ayham Alnabulsi

Institute: Vertebrate Antibodies Limited

Tool Details
Target Details
Applications
Handling

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-Cytochrome P450 2E1 [M12P4H2]
  • Research fields: Cancer;Cell signaling and signal transduction;Metabolism;Tissue-specific biology
  • Clone: M12P4H2
  • Tool sub type: Primary antibody
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Strain: Balb/c
  • Reactivity: Human
  • Host: Mouse
  • Application: IHC ; WB
  • Description: Metabolizes several precarcinogens, drugs, and solvents to reactive metabolites. Inactivates a number of drugs and xenobiotics and also bioactivates many xenobiotic substrates to their hepatotoxic or carcinogenic forms.
  • Immunogen: Ovalbumin-conjugated synthetic peptide HIGFGCIPPR (C-terminal sequence)
  • Isotype: IgG1 lambda
  • Myeloma used: P3X63Ag8.653
  • Recommended controls: IHC: formalin-fixed, paraffin-embedded human liver sections; WB: pooled human liver microsomes

Target Details

  • Target: Cytochrome P450, family 2, subfamily E, polypeptide 1 (CYP2E1)
  • Tissue cell line specificity: IHC: formalin-fixed, paraffin-embedded human liver sections; WB: pooled human liver microsomes
  • Target background: Metabolizes several precarcinogens, drugs, and solvents to reactive metabolites. Inactivates a number of drugs and xenobiotics and also bioactivates many xenobiotic substrates to their hepatotoxic or carcinogenic forms.

Applications

  • Application: IHC ; WB

Handling

  • Format: Liquid
  • Concentration: 1 mg/ml
  • Unit size: 100 ug
  • Storage buffer: PBS with 0.02% azide
  • Storage conditions: 4° C
  • Shipping conditions: Shipping at 4° C